Publications by authors named "E P Krenning"

Claim this Profile
R
Relationship Between Best Tumor Shrinkage and Progression-Free Survival and Overall Survival in Patients With Progressive Midgut Neuroendocrine Tumors Treated With [Lu]Lu-DOTA-TATE: Ad Hoc Analysis of the Phase III NETTER-1 Trial.
Marianne Pavel, Martyn E Caplin, Philippe Ruszniewski, Marianna Hertelendi, Eric P Krenning

Cancer Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry of [Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial.
Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Erik S Mittra, Harshad R Kulkarni, Eric Krenning

J Nucl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reshaping [Tc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTSR-Positive Cancer Theranostics.
Panagiotis Kanellopoulos, Berthold A Nock, Eric P Krenning, Theodosia Maina

Pharmaceutics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results.
Maria Bibika, Panagiotis Kanellopoulos, Maritina Rouchota, George Loudos, Berthold A Nock, Eric P Krenning

Pharmaceutics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [In]In-Radioligands: Synthesis and Preclinical Profile.
Aikaterini Tatsi, Theodosia Maina, Beatrice Waser, Eric P Krenning, Marion de Jong

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis